NAPODANO, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 15.786
AS - Asia 8.940
EU - Europa 4.047
AF - Africa 1.461
SA - Sud America 1.415
OC - Oceania 131
Continente sconosciuto - Info sul continente non disponibili 66
Totale 31.846
Nazione #
US - Stati Uniti d'America 15.021
SG - Singapore 2.840
CN - Cina 1.540
VN - Vietnam 1.281
HK - Hong Kong 908
BR - Brasile 846
IT - Italia 477
FI - Finlandia 366
DE - Germania 360
FR - Francia 344
SE - Svezia 308
BD - Bangladesh 279
IN - India 277
PL - Polonia 261
GB - Regno Unito 242
RU - Federazione Russa 218
NL - Olanda 178
UA - Ucraina 172
TR - Turchia 148
JP - Giappone 141
AR - Argentina 134
IQ - Iraq 126
PK - Pakistan 105
PH - Filippine 101
CA - Canada 93
SA - Arabia Saudita 89
ZA - Sudafrica 84
IE - Irlanda 79
MX - Messico 78
KR - Corea 77
EC - Ecuador 70
EG - Egitto 62
CO - Colombia 61
ID - Indonesia 61
ES - Italia 58
JM - Giamaica 58
LB - Libano 57
CL - Cile 55
HU - Ungheria 55
AT - Austria 54
JO - Giordania 54
UZ - Uzbekistan 54
BE - Belgio 52
CI - Costa d'Avorio 52
MY - Malesia 52
LV - Lettonia 51
PY - Paraguay 51
VE - Venezuela 49
AE - Emirati Arabi Uniti 48
GR - Grecia 48
NP - Nepal 48
MA - Marocco 47
DZ - Algeria 46
GT - Guatemala 46
TN - Tunisia 46
CV - Capo Verde 45
TH - Thailandia 45
SK - Slovacchia (Repubblica Slovacca) 44
BF - Burkina Faso 43
CH - Svizzera 43
AO - Angola 42
CG - Congo 42
PA - Panama 42
AU - Australia 41
ET - Etiopia 41
IL - Israele 41
KE - Kenya 41
AZ - Azerbaigian 40
BB - Barbados 40
IR - Iran 40
PE - Perù 40
PS - Palestinian Territory 40
IS - Islanda 39
MK - Macedonia 39
NI - Nicaragua 39
SO - Somalia 39
GH - Ghana 38
HR - Croazia 38
KG - Kirghizistan 38
LA - Repubblica Popolare Democratica del Laos 38
NO - Norvegia 38
TW - Taiwan 38
BJ - Benin 37
BO - Bolivia 37
BZ - Belize 37
CZ - Repubblica Ceca 37
GF - Guiana Francese 37
GN - Guinea 37
SN - Senegal 37
AL - Albania 36
CM - Camerun 36
PT - Portogallo 36
BY - Bielorussia 35
YE - Yemen 35
GA - Gabon 34
HN - Honduras 34
KZ - Kazakistan 34
MN - Mongolia 34
RO - Romania 34
UY - Uruguay 34
Totale 30.243
Città #
Singapore 1.745
Ashburn 1.700
Fairfield 1.602
San Jose 1.556
Chandler 1.131
Woodbridge 898
Hong Kong 808
Houston 802
Ann Arbor 665
Wilmington 584
Jacksonville 576
Seattle 553
Cambridge 549
Ho Chi Minh City 363
Santa Clara 361
Beijing 313
Hanoi 292
Boardman 269
Princeton 250
Los Angeles 218
San Diego 190
Bytom 187
Lauterbourg 162
Helsinki 156
Medford 151
New York 142
Roxbury 134
Nanjing 126
Des Moines 111
Tokyo 104
São Paulo 91
Dong Ket 88
Amsterdam 84
Da Nang 75
Buffalo 71
Istanbul 64
Guangzhou 62
Hefei 56
Chicago 55
Dublin 55
Baghdad 54
Orem 52
Abidjan 49
Amman 48
Riga 47
Tashkent 47
Dallas 46
London 46
Padova 44
Warsaw 44
Panama City 41
Haiphong 40
Frankfurt am Main 39
Baku 38
Brooklyn 38
Praia 38
Seoul 38
Conakry 37
Johannesburg 37
Luanda 37
Managua 37
Bridgetown 36
Jeddah 36
Kingston 36
Nairobi 36
Dakar 35
Lahore 35
Addis Ababa 34
Vienna 34
Cotonou 33
Ulan Bator 33
Vientiane 33
Bishkek 32
Nanchang 32
Accra 31
Libreville 31
Ouagadougou 31
Shanghai 31
Cairo 30
Harare 30
Kuala Lumpur 30
Milan 30
Rio de Janeiro 30
Rome 30
Stockholm 30
Council Bluffs 29
Kingstown 29
Atlanta 28
Cayenne 28
Guatemala City 28
Hebei 28
Lusaka 28
Ogden 28
Reykjavik 28
Athens 27
Budapest 27
Chennai 27
Dushanbe 27
Lima 27
Montevideo 27
Totale 19.491
Nome #
2-year results of CoreValve implantation through the subclavian access: A propensity-matched comparison with the femoral access 477
Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve Implantation. 286
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 282
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. 279
"Of coronary arteries and men": The fight of a dialysis patient against his coronary arteries 277
Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis. 266
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve 265
Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) 262
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 262
Coronary vasospasm complicated by ventricular fibrillation: arrhythmogenic morphological substrates detected in vivo by cardiac magnetic resonance. 260
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 256
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 253
LAD coronary artery myocardial bridging and apical ballooning syndrome. 251
Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study. 248
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 244
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 243
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 243
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. 242
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 241
Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. 240
Relation of aortic valve weight to severity of aortic stenosis. 239
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. 236
Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. 233
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 233
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 232
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 230
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. 230
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation. 229
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: A real-life multicenter experience. 229
Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. 228
Conduction Abnormalities after Transcatheter Aortic Valve Implantation for Calcitic Aortic Valve Disease 226
A combination of drug-eluting stents and bioresorbable vascular scaffolds in the treatment of multivessel coronary artery disease 222
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 220
PCI Versus CABG for Multivessel Coronary Disease in Diabetics 218
Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. 217
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. 216
Chronic kidney disease and percutaneous coronary interventions with drug-eluting stents: Does the K/DOQI classification matter? 215
Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: the rule of 40 215
Treatment of spontaneous coronary artery dissection by bio-resorbable vascular scaffolds 215
Atypical (mid-ventricular) Takotsubo syndrome in a survival of out-of-hospital ventricular fibrillation: cause or consequence? 213
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 213
PCI versus CABG for multivessel coronary disease in diabetics 210
Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry. 209
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve revalving system 209
Valve replacement for severe aortic stenosis with low transvalvular gradient and left ventricular ejection fraction exceeding 0.50. 208
Usefulness and Validation of the Survival posT TAVI Score for Survival After Transcatheter Aortic Valve Implantation for Aortic Stenosis. 205
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 203
Comparison of Variables in Men Versus Women Undergoing Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis (from Italian Multicenter CoreValve Registry) 203
Microvasculopathy Preceeds Epicardial Coronary Stenosis in Heart Transplant Patients with Cardiac Allograft Vasculopathy 202
Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes 200
[High-risk ST-elevation acute coronary syndrome in a patient with multivessel coronary artery disease complicated by refractory cardiogenic shock undergoing complex percutaneous coronary revascularization: role and timing of mechanical circulatory support devices] 200
Left ventricular pseudoaneurysm after transapical aortic valve-in-valve implantation: Use of transthoracic 3D echocardiography for guiding therapeutic approach 200
The "plastic healing concept": Implantation of bioabsorbable scaffolds in spontaneous coronary artery dissection 199
Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis 198
Thrombus burden and myocardial damage during primary percutaneous coronary intervention. 196
Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry). 196
Atrial septal mass: Transesophageal echocardiographic assessment 196
Moderate-to-severe ischemic mitral regurgitation and multivessel coronary artery disease: Impact of different treatment on survival and rehospitalization. 195
Age-related outcome of percutaneous mitral balloon valvuloplasty 193
Atrial septal mass: Transesophageal echocardiographic assessment 193
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 193
Transcatheter aortic valve implantation in patients younger than 75 years: Guidelines-based patients selection and clinical outcome 190
Impact of drug-eluting stent generation on patient- and stent-related adverse events of diabetic patients treated by percutaneous coronary intervention. 189
Late stent fracture - A potential role of left ventricular dilatation 188
Predictors and time-related impact of distal embolization during primary angioplasty 186
Transcatheter valve-in-valve implantation using CoreValve revalving system for failed surgical aortic bioprostheses 185
Ventricular assist devices. 184
Echocardiographic follow-up after transcatheter aortic valve replacement 184
Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: Results of self-expandable and balloon-expandable transcatheter heart valves 184
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement 183
Prevalence and Impact of Atrial Fibrillation in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement An Analysis from the SOURCE XT Prospective Multicenter Registry 183
Pratica clinica attuale e trend di variazione in cardiologia interventistica strutturale. Risultati di una survey multicentrica SICI-GISE in sei Regioni italiane: Toscana, Lombardia, Veneto, Emilia-Romagna, Campania e Puglia 180
Relationship Among Primary Angioplasty Related Delay, Risk Of The Patients With St Elevation Myocardial Infarction And Survival Benefit Of Primary Angiopasty Over Fibrinolysis 178
Assessing the Impact of Distal Embolization on Myocardial and Microvascular Damage during primary-Percutaneous Coronary Intervention: A Prospective Magnetic Resonance Study 177
Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. 177
Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia 176
Management and outcome of spontaneous coronary artery dissection: Conservative therapy versus revascularization 176
Coronary flow reserve by contrast-enhanced transthoracic Echocardiography predicts maximal epicardial intimal thickness in heart transplant patients with normal coronary angiogram 174
Positive stress test in a patient with patent coronary artery grafts 174
Transcatheter aortic valve implantation and bleeding: focus on Valve Academic Research Consortium-2 classification. 173
The Impact of Distal Embolization on Myocardial and Microvascular Damage is not Mediated by Reduction in Epicardial Flow 172
Impact of angiographic assessment of myocardial reperfusion on outcome after primary angioplasty in patients with cardiogenic shock 172
Relation of patient age to outcome of percutaneous mitral valvuloplasty 172
A comparison of percutaneous treatment with drug eluting stent implantation versus by pass surgery in diabetic patients with multivessel coronary artery disease a single center experience 171
Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Results from the global valve-in-valve registry 171
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 171
Myocardial And Microvascular Injury In Diabetic Patients Treated By Primary Angioplasty: Is It Larger Compared With That Of Non Diabetic Patients With Similar Risk Profile? 171
Neo-atherosclerosis in very late stent thrombosis of drug eluting stent 170
Adjunctive Thrombectomy in Acute Myocardial Infarction: For Some but Not for All 170
High-risk percutaneous coronary intervention using the intracardiac microaxial pump 'Impella Recover' 169
Initial Q Wave at Presentation of Acute Myocardial Infarction is Better Than Time to Treatment in Predicting Myocardial and Microvascular Damage in Patients with Anterior Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 168
Duration of ischemia is a major determinant of transmurality and microvascular obstruction assessed by magnetic resonance after primary angioplasty 168
Transcatheter replacement of failed bioprosthetic valves: Large multicenter assessment of the effect of implantation depth on hemodynamics after aortic valve-in-valve 168
Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. 166
Newer generation self-expandable coronary stent bail-out re-sheathing 166
[New Technologies in coronary interventional cardiology: results from the first inter-regional survey promoted by SICI-GISE in four regions of northern Italy ("the GISE TOLOVE" area: Tuscany, Lombardy, Veneto, Emilia-Romagna)] 165
Meta-analysis of randomized trials of postconditioning in ST-elevation myocardial infarction. 163
Impact of age on immediate and late results of percutaneous mitral balloon valvuloplasty in a series of 626 patients. 162
Discrepancies between catheter and Doppler estimates of aortic stenosis: The role of pressure recovery evaluated 'in vivo' 162
Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation. 159
Totale 20.891
Categoria #
all - tutte 91.016
article - articoli 88.655
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 577
Totale 180.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.421 47 367 259 169 85 192 124 242 101 36 238 561
2022/20232.114 429 262 87 257 316 257 6 132 233 20 86 29
2023/2024791 26 146 83 56 74 62 42 54 44 13 95 96
2024/20253.709 38 208 170 141 554 130 155 287 306 128 652 940
2025/202615.805 544 1.351 2.100 2.443 1.456 661 2.377 1.381 1.666 841 578 407
2026/2027237 237 0 0 0 0 0 0 0 0 0 0 0
Totale 31.968